Supemtek Tetra is a vaccine used to protect adults and children from 9 years of age against influenza (flu). Influenza is mainly caused by two kinds of influenza virus, known as influenza A and B. Each of these circulate as different strains and subtypes, which change over time. Supemtek Tetra contains proteins of four different influenza A and B virus strains (type A-H1N1, type A-H3N2 and two type B strains), chosen based on the official recommendation for the annual flu season.
Therapeutic Indication
### Therapeutic indication Supemtek Tetra is indicated for active immunization for the prevention of influenza disease in adults and children from 9 years of age and older. Supemtek Tetra should be used in accordance with official recommendations.
Therapeutic Area (MeSH)
ATC Code
J07BB02
ATC Item
influenza, inactivated, split virus or surface antigen
Pharmacotherapeutic Group
Vaccines
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Influenza A virus subtype H1N1 haemagglutinin, recombinant | N/A | Influenza A virus subtype H1N1 haemagglutinin, recombinant |
| Influenza A virus subtype H3N2 haemagglutinin, recombinant | N/A | Influenza A virus subtype H3N2 haemagglutinin, recombinant |
| Influenza B virus Victoria lineage haemagglutinin, recombinant | N/A | Influenza B virus Victoria lineage haemagglutinin, recombinant |
| Influenza B virus Yamagata lineage haemagglutinin, recombinant | N/A | Influenza B virus Yamagata lineage haemagglutinin, recombinant |
EMA Name
Supemtek
Medicine Name
Supemtek Tetra (previously Supemtek)
Aliases
N/ANo risk management plan link.
